HBK Investments »

Drugs Made In Amer Acq Ii shares owned by HBK Investments

Quarter-by-quarter ownership of Drugs Made In Amer Acq Ii (DMII) shares owned by HBK Investments from 13F filings

Historical chart of HBK Investments investment in Drugs Made In Amer Acq Ii

Tip: Access up to 7 years of quarterly data

All positions including Drugs Made In Amer Acq Ii held by HBK Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Drugs Made In Amer Acq Ii by HBK Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.0M 500k 9.90

More positions owned by HBK Investments

NVIDIA Corporation Put Option (NVDA)
Cyberark Software SHS (CYBR)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
EXACT Sciences Corporation (EXAS)
Hologic (HOLX)
Norfolk Southern (NSC)
Ceridian Hcm Hldg
Confluent Class A Com (CFLT)
Chart Industries (GTLS)
Electronic Arts (EA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Comerica Incorporated
Avidity Biosciences Ord (RNA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Frontier Communications Pare

View all positions for HBK Investments

Top funds holding Drugs Made In Amer Acq Ii

Magnetar Financial
Glazer Capital
Vivaldi Asset Management
Hudson Bay Capital Management
Tenor Capital Management
Millennium Management
Polar Securities
HGC Investment Management
CNH Partners
Karpus Investment Management
Aristeia Capital
Wolverine Asset Management
D. E. Shaw & Co
OMERS Administration Corporation
Davidson Kempner Capital Management

View all funds holding Drugs Made In Amer Acq Ii